Gamal Rayan

Dr. Gamal Rayan

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2010 in Sensors
Verified
Journal Article
Open access
PDF file
GRGamal Rayan
Gamal Rayan
JGJean-Erik Guet
Jean-Erik Guet
NTNicolas Taulier
Nicolas Taulier
FPFrédéric Pincet
Frédéric Pincet
WUWladimir Urbach
Wladimir Urbach
This review examines some recent applications of fluorescence recovery after photobleaching (FRAP) to biopolymers, while mainly focusing on membrane protein studies. Initially, we discuss the lateral diffusion of membrane proteins, as measured by FRAP. Then, we talk about the use of FRAP to probe interactions between membrane proteins by obtaining fundamental information such as geometry and stoichiometry of the interacting complex. Afterwards, we discuss some applications of FRAP at the cellular level as well as the level of organisms. We conclude by comparing diffusion coefficients obtained by FRAP and several other alternative methods.

1 January 2003 in International Journal of Radiation Oncology, Biology, Physics
Verified
Journal Article
Closed access
GRGamal Rayan
Gamal Rayan
LDLaura A Dawson
Laura A Dawson
ABAndrea Bezjak
Andrea Bezjak
ALAnthea Lau
Anthea Lau
AFAnthony W Fyles
Anthony W Fyles
Kate VallisKate Vallis
Kate Vallis

1 February 2022 in Biophysical Chemistry
Verified
Journal Article
Closed access
VAVladimir Adrien
Vladimir Adrien
GRGamal Rayan
Gamal Rayan
KAKsenia Astafyeva
Ksenia Astafyeva
Isabelle BroutinIsabelle Broutin
Isabelle Broutin
MPMartin Picard
Martin Picard
NTNicolas Taulier
Nicolas Taulier

21 January 2009 in The Journal of Physical Chemistry B
Verified
Journal Article
Closed access
GRGamal Rayan
Gamal Rayan
ATAlekos D. Tsamaloukas
Alekos D. Tsamaloukas
JMJr. Robert B. Macgregor
Jr. Robert B. Macgregor
Heiko HeerklotzHeiko Heerklotz
Heiko Heerklotz

Verified
Journal Article
Open access
PDF file
MSMike Thomas Springer
Mike Thomas Springer
ZBZeynep Aydin Burakgazi
Zeynep Aydin Burakgazi
ADAnastasiia Domukhovska
Anastasiia Domukhovska
BNBen Nafchi
Ben Nafchi
MBMichael Connor Beary
Michael Connor Beary
SZShoshanna N. Zucker
Shoshanna N. Zucker
Hypoxia is a critical factor affecting tissue homeostasis that dramatically alters the tumor microenvironment (TME) through genetic, metabolic, and structural changes, promoting tumor survival and proliferation. Hypoxia-inducible factor-1α (HIF-1α) plays a central role in this process by regulating hundreds of genes involved in the processes of tumorigenesis, angiogenesis, metabolic reprogramming, and immune evasion. This review provides a comprehensive examination of the role of HIF-1α in hypoxia and how hypoxia weakens intercellular junctions—including gap junctions, adherens junctions, tight junctions, and desmosomes. The disruption of gap junctions decreases intercellular communication, which alters signal transduction cascades and tumor suppressive properties. Adherens junctions are comprised of proteins that characterize the tissues and link cells to the actin cytoskeleton, whereby their disruption promotes the epithelial-to-mesenchymal transition (EMT). Under hypoxic conditions, the tight junction proteins are dysregulated, altering paracellular transport and cell polarity. In addition, desmosomes provide linkage to intermediate filaments, and hypoxia compromises tissue integrity. Collectively, the influence of hypoxia on cellular junctions promotes tumorigenesis through reducing cell communication, cytoskeletal interactions, and altering signaling pathways. Activation of matrix metalloproteinases (MMPs) further degrades the extracellular matrix and enhances tumor invasion and metastasis. This process also involves hypoxia-induced angiogenesis, regulated by HIF-1α. A comprehensive understanding of the mechanisms of hypoxia-driven tumor adaptation is essential for developing effective therapeutic strategies. Furthermore, this review examines current treatments aimed at targeting HIF-1α and explores future directions to enhance treatment efficacy and improve patient outcomes.

26 July 2005 in The Journal of Physical Chemistry B
Verified
Journal Article
Closed access
GRGamal Rayan
Gamal Rayan
RMRobert B. Macgregor
Robert B. Macgregor